| |
| |
|
| Insider
Information: |
White Anne E. |
| Relationship: |
EVP & Pres, Lilly Neur... |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
65,569 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,095,517 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,569 |
|
|
| Total
Value |
$48,095,517 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP & Pres, Lilly Neur... |
2024-02-12 |
65,569 |
2018-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2024-02-12 |
4 |
A |
$737.26 |
$3,953,925 |
D/D |
5,363 |
65,569 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2024-02-01 |
4 |
D |
$645.61 |
$1,190,505 |
D/D |
(1,844) |
60,206 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,124 |
62,050 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2023-02-13 |
4 |
AS |
$346.47 |
$866,175 |
D/D |
(2,500) |
57,926 |
0 |
% |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2023-02-10 |
4 |
AS |
$342.76 |
$856,900 |
D/D |
(2,500) |
60,426 |
0 |
% |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2023-02-10 |
4 |
A |
$345.12 |
$2,954,917 |
D/D |
8,562 |
62,926 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2023-02-01 |
4 |
D |
$344.15 |
$1,119,176 |
D/D |
(3,252) |
54,364 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres, Lilly Neuroscience |
• – – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,264 |
57,616 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Neuroscience |
• – – |
2022-02-09 |
4 |
A |
$243.27 |
$2,760,628 |
D/D |
11,348 |
50,352 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Neuroscience |
• – – |
2022-02-01 |
4 |
D |
$245.39 |
$1,031,620 |
D/D |
(4,204) |
39,004 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Neuroscience |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,368 |
43,208 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2021-02-08 |
4 |
A |
$205.77 |
$970,823 |
D/D |
4,718 |
33,840 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2020-02-11 |
4 |
A |
$144.25 |
$1,021,146 |
D/D |
7,079 |
29,122 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2019-10-25 |
4 |
B |
$108.84 |
$108,840 |
D/D |
1,000 |
22,043 |
2.74 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2019-02-04 |
4 |
A |
$120.17 |
$870,752 |
D/D |
7,246 |
21,043 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2018-12-02 |
4 |
D |
$118.64 |
$392,224 |
D/D |
(3,306) |
13,797 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres-Lilly Oncology |
• – – |
2018-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
17,103 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
